![Philippe Glatz](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Philippe Glatz
President at Clinique des Grangettes SA
Profile
Philippe Glatz has worked as a Director at Abionic SA since 2018 and currently holds the position.
He is also the President at Clinique des Grangettes SA, where he currently works.
Philippe Glatz active positions
Companies | Position | Start |
---|---|---|
Clinique des Grangettes SA
![]() Clinique des Grangettes SA Medical/Nursing ServicesHealth Services Clinique des Grangettes SA provides medical health care services. It offers medical services, like orthopedics, cardiology, post-operative care, as well as emergency services, cardiology, oncology, and surgery. The company was founded in 1918 and is headquartered in Chêne-Bougeries, Switzerland. | President | - |
Abionic SA
![]() Abionic SA Medical SpecialtiesHealth Technology Abionic SA develops biomedical diagnostic devices. It specializes in in vitro diagnostic devices for allergies detection. The firm?s products include abioSCOPE and abioKIT. Its services encompass research, development, and commercialization of its products. The company was founded by Nicolas Durand, Iwan M?rki, and Theo Lasser in 2010 and is headquartered in Lausanne, Switzerland. | Director/Board Member | 01/02/2018 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Clinique des Grangettes SA
![]() Clinique des Grangettes SA Medical/Nursing ServicesHealth Services Clinique des Grangettes SA provides medical health care services. It offers medical services, like orthopedics, cardiology, post-operative care, as well as emergency services, cardiology, oncology, and surgery. The company was founded in 1918 and is headquartered in Chêne-Bougeries, Switzerland. | Health Services |
Abionic SA
![]() Abionic SA Medical SpecialtiesHealth Technology Abionic SA develops biomedical diagnostic devices. It specializes in in vitro diagnostic devices for allergies detection. The firm?s products include abioSCOPE and abioKIT. Its services encompass research, development, and commercialization of its products. The company was founded by Nicolas Durand, Iwan M?rki, and Theo Lasser in 2010 and is headquartered in Lausanne, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Philippe Glatz